{"id":"https://openalex.org/W2152371950","doi":"https://doi.org/10.1093/jac/dkr088","title":"Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections?","display_name":"Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections?","publication_year":2011,"publication_date":"2011-03-11","ids":{"openalex":"https://openalex.org/W2152371950","doi":"https://doi.org/10.1093/jac/dkr088","mag":"2152371950","pmid":"https://pubmed.ncbi.nlm.nih.gov/21398297"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dkr088","doi":"https://doi.org/10.1093/jac/dkr088","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkr088","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032275098","display_name":"Cliodna A. M. McNulty","orcid":"https://orcid.org/0000-0003-4969-5360","observed_orcids":["https://orcid.org/0000-0003-4969-5360"]},"institutions":[{"id":"https://openalex.org/I4210148984","display_name":"Gloucestershire Royal Hospital","ror":"https://ror.org/05gh5ar80","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802266942","https://openalex.org/I4210148984"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Cliodna A. M. McNulty","raw_affiliation_strings":["Health Protection Agency Primary Care Unit, Microbiology Department, Gloucestershire Royal Hospital, Great Western Road, Gloucester GL13NN, UK. cliodna.mcnulty@hpa.org.uk","Health Protection Agency Primary Care Unit, Microbiology Department, Gloucestershire Royal Hospital, Great Western Road, Gloucester GL1 3NN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Protection Agency Primary Care Unit, Microbiology Department, Gloucestershire Royal Hospital, Great Western Road, Gloucester GL13NN, UK. cliodna.mcnulty@hpa.org.uk","institution_ids":["https://openalex.org/I4210148984"]},{"raw_affiliation_string":"Health Protection Agency Primary Care Unit, Microbiology Department, Gloucestershire Royal Hospital, Great Western Road, Gloucester GL1 3NN, UK","institution_ids":["https://openalex.org/I4210148984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023492410","display_name":"Gemma Lasseter","orcid":"https://orcid.org/0000-0001-7482-6305","observed_orcids":["https://orcid.org/0000-0001-7482-6305"]},"institutions":[{"id":"https://openalex.org/I4210148984","display_name":"Gloucestershire Royal Hospital","ror":"https://ror.org/05gh5ar80","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802266942","https://openalex.org/I4210148984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gemma M. Lasseter","raw_affiliation_strings":["Health Protection Agency Primary Care Unit, Microbiology Department, Gloucestershire Royal Hospital, Great Western Road, Gloucester GL1 3NN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Protection Agency Primary Care Unit, Microbiology Department, Gloucestershire Royal Hospital, Great Western Road, Gloucester GL1 3NN, UK","institution_ids":["https://openalex.org/I4210148984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005539896","display_name":"Andr\u00e9 Charlett","orcid":"https://orcid.org/0000-0001-7154-0432","observed_orcids":["https://orcid.org/0000-0001-7154-0432"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andr\u00e9 Charlett","raw_affiliation_strings":["Health Protection Agency, Centre for Infections, Statistics Unit, 61 Colindale Avenue, London NW9 5EQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Protection Agency, Centre for Infections, Statistics Unit, 61 Colindale Avenue, London NW9 5EQ, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111942376","display_name":"A. M. Lovering","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1307034911","display_name":"North Bristol NHS Trust","ror":"https://ror.org/036x6gt55","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307034911","https://openalex.org/I4405276282"]},{"id":"https://openalex.org/I2801253297","display_name":"Southmead Hospital","ror":"https://ror.org/05d576879","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801253297","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andy Lovering","raw_affiliation_strings":["Bristol Centre for Antimicrobial Research & Evaluation, North Bristol NHS Trust, Department of Medical Microbiology, Southmead Hospital, Lime Walk Building, Westbury-on-Trym, Bristol BS10 5NB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Centre for Antimicrobial Research & Evaluation, North Bristol NHS Trust, Department of Medical Microbiology, Southmead Hospital, Lime Walk Building, Westbury-on-Trym, Bristol BS10 5NB, UK","institution_ids":["https://openalex.org/I1307034911","https://openalex.org/I2801253297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080059575","display_name":"Rebecca Howell\u2010Jones","orcid":"https://orcid.org/0000-0002-9553-0367","observed_orcids":["https://orcid.org/0000-0002-9553-0367"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca Howell-Jones","raw_affiliation_strings":["HIV & STI Department, Health Protection Agency, Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV & STI Department, Health Protection Agency, Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060427520","display_name":"Alasdair P. MacGowan","orcid":"https://orcid.org/0000-0002-6720-5268","observed_orcids":["https://orcid.org/0000-0002-6720-5268"]},"institutions":[{"id":"https://openalex.org/I1307034911","display_name":"North Bristol NHS Trust","ror":"https://ror.org/036x6gt55","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307034911","https://openalex.org/I4405276282"]},{"id":"https://openalex.org/I2801253297","display_name":"Southmead Hospital","ror":"https://ror.org/05d576879","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801253297","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alasdair MacGowan","raw_affiliation_strings":["Bristol Centre for Antimicrobial Research & Evaluation, North Bristol NHS Trust, Department of Medical Microbiology, Southmead Hospital, Lime Walk Building, Westbury-on-Trym, Bristol BS10 5NB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Centre for Antimicrobial Research & Evaluation, North Bristol NHS Trust, Department of Medical Microbiology, Southmead Hospital, Lime Walk Building, Westbury-on-Trym, Bristol BS10 5NB, UK","institution_ids":["https://openalex.org/I1307034911","https://openalex.org/I2801253297"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077591623","display_name":"Mike D. Thomas","orcid":"https://orcid.org/0000-0001-5939-1155","observed_orcids":["https://orcid.org/0000-0001-5939-1155"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mike Thomas","raw_affiliation_strings":["Department of Academic Primary Care, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen AB25 2AY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Academic Primary Care, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen AB25 2AY, UK","institution_ids":["https://openalex.org/I195460627"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5032275098"],"corresponding_institution_ids":["https://openalex.org/I4210148984"],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":1.3214,"has_fulltext":false,"cited_by_count":75,"citation_normalized_percentile":{"value":0.78291168,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"66","issue":"6","first_page":"1396","last_page":"1404"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/primary-care-prescribing","display_name":"primary care prescribing","score":0.7200000286102295},{"id":"https://openalex.org/keywords/urinary-tract-infection","display_name":"urinary tract infection","score":0.9290000200271606},{"id":"https://openalex.org/keywords/cephalexin","display_name":"cephalexin","score":0.9620000123977661},{"id":"https://openalex.org/keywords/amoxicillin-clavulanic-acid","display_name":"amoxicillin-clavulanic acid","score":0.9909999966621399},{"id":"https://openalex.org/keywords/antimicrobial-stewardship","display_name":"antimicrobial stewardship","score":0.7289999723434448},{"id":"https://openalex.org/keywords/recurrent-urinary-tract-infection","display_name":"recurrent urinary tract infection","score":0.6480000019073486},{"id":"https://openalex.org/keywords/general-practitioners","display_name":"general practitioners","score":0.503000020980835}],"concepts":[{"id":"https://openalex.org/C2778961191","wikidata":"https://www.wikidata.org/wiki/Q411417","display_name":"Cefalexin","level":4,"score":0.9278162717819214},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7922762632369995},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.7147324681282043},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.5507071614265442},{"id":"https://openalex.org/C2779708577","wikidata":"https://www.wikidata.org/wiki/Q201928","display_name":"Amoxicillin","level":3,"score":0.5365611910820007},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.47245386242866516},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.4494037330150604},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.38258039951324463},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34652942419052124},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.18086457252502441},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.14998215436935425},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06963711977005005}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002506","descriptor_name":"Cephalexin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D006302","descriptor_name":"Health Services Research","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011307","descriptor_name":"Drug Prescriptions","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D011320","descriptor_name":"Primary Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014552","descriptor_name":"Urinary Tract Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014552","descriptor_name":"Urinary Tract Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D019980","descriptor_name":"Amoxicillin-Potassium Clavulanate Combination","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1093/jac/dkr088","doi":"https://doi.org/10.1093/jac/dkr088","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkr088","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:21398297","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21398297","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:research-information.bris.ac.uk:openaire_cris_publications/55abca7f-9a9e-4743-b5ca-f87b53b20f10","doi":null,"is_oa":false,"landing_page_url":"https://research-information.bris.ac.uk/en/publications/55abca7f-9a9e-4743-b5ca-f87b53b20f10","pdf_url":null,"source":{"id":"https://openalex.org/S7407055359","display_name":"Explore Bristol Research","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"McNulty, C A M, Lasseter, G M, Charlett, A, Lovering, A, Howell-Jones, R, MacGowan, A & Thomas, M 2011, 'Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections?', Journal of Antimicrobial Chemotherapy, vol. 66, no. 6, pp. 1396-404. https://doi.org/10.1093/jac/dkr088","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:open-archive.highwire.org:jac:dkr088v1","doi":null,"is_oa":false,"landing_page_url":"http://jac.oxfordjournals.org/cgi/content/short/dkr088v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:research-information.bris.ac.uk:publications/55abca7f-9a9e-4743-b5ca-f87b53b20f10","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/1983/55abca7f-9a9e-4743-b5ca-f87b53b20f10","pdf_url":null,"source":{"id":"https://openalex.org/S4306400895","display_name":"Bristol Research (University of Bristol)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I36234482","host_organization_name":"University of Bristol","host_organization_lineage":["https://openalex.org/I36234482"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"McNulty, C A M, Lasseter, G M, Charlett, A, Lovering, A, Howell-Jones, R, MacGowan, A & Thomas, M 2011, 'Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections?', Journal of Antimicrobial Chemotherapy, vol. 66, no. 6, pp. 1396-404. https://doi.org/10.1093/jac/dkr088","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320030","display_name":"British Society for Antimicrobial Chemotherapy","ror":"https://ror.org/04yw9eb05"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W26020441","https://openalex.org/W183845132","https://openalex.org/W221578851","https://openalex.org/W1517179628","https://openalex.org/W1722056074","https://openalex.org/W1945795339","https://openalex.org/W2027411995","https://openalex.org/W2058585881","https://openalex.org/W2062316742","https://openalex.org/W2097981845","https://openalex.org/W2106447447","https://openalex.org/W2112178875","https://openalex.org/W2117564466","https://openalex.org/W2118728578","https://openalex.org/W2119175962","https://openalex.org/W2129097224","https://openalex.org/W2148959780","https://openalex.org/W2165296911","https://openalex.org/W2166907962","https://openalex.org/W6640469687"],"related_works":["https://openalex.org/W2119175962","https://openalex.org/W3092309756","https://openalex.org/W4280494331","https://openalex.org/W4324044523","https://openalex.org/W2019646588","https://openalex.org/W2621378427","https://openalex.org/W2902838609","https://openalex.org/W3106812425","https://openalex.org/W1967787561","https://openalex.org/W3118834145"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Using":[1],"a":[2,14,35,49,61,127,132,215],"prospective":[3],"interrupted":[4],"time":[5],"series":[6],"design,":[7],"our":[8],"goal":[9],"was":[10,64,104,112,119,233],"to":[11,23,25,34,52,66,89,191,235,261],"determine":[12,90],"whether":[13],"change":[15,36,196,230],"in":[16,37,71,79,125,142,146,155,160,164,170,179,183,197,231],"urine":[17,62],"antibiotic":[18,38,46,91,168,198,211,219,251],"susceptibility":[19,212],"reporting":[20,199,213,255],"from":[21],"co-amoxiclav":[22,107,111,241],"cefalexin":[24,103,239],"community":[26],"clinicians":[27],"served":[28],"by":[29,115,152,221,253],"Southmead":[30],"General":[31],"Hospital":[32],"led":[33],"prescribing.":[39],"METHODS:":[40],"We":[41],"used":[42],"longitudinal":[43],"data":[44,88,176,186,204,224],"on":[45,218],"prescribing":[47,54,75,92,100,108,169,189,220,232],"using":[48],"clinician":[50],"questionnaire":[51,138],"identify":[53],"for":[55,74,76,93,121,242],"urinary":[56],"tract":[57],"infections":[58],"(UTIs)":[59],"when":[60,102,110],"specimen":[63,133],"submitted":[65],"microbiology;":[67],"MIQUEST":[68,153,185],"computer":[69],"search":[70],"general":[72,128],"practices":[73],"all":[77,94],"UTIs":[78],"the":[80,116,137,156,171,195,229,236],"community;":[81],"and":[82,85,98,106,166,240],"Prescribing":[83],"Analysis":[84],"Cost":[86],"(PACT)":[87],"infections.":[95,246],"RESULTS:":[96],"Cefalexin":[97],"cephalosporin":[99],"increased":[101],"reported":[105,114],"decreased":[109],"not":[113],"laboratory.":[117],"This":[118],"seen":[120],"episodes":[122,148],"of":[123,149,228,238],"UTI":[124,150],"which":[126],"practitioner":[129],"(GP)":[130],"sent":[131],"as":[134],"determined":[135,173],"with:":[136],"results":[139],"(9-fold":[140],"rise":[141],"cephalosporins,":[143],"70%":[144],"fall":[145],"co-amoxiclav);":[147,165],"identified":[151],"searches":[154],"practice":[157,172],"(50%":[158],"increase":[159,178],"cefalexin,":[161,180],"25%":[162],"reduction":[163,182],"overall":[167],"with":[174],"PACT":[175],"(20%":[177],"8%":[181],"co-amoxiclav).":[184],"indicated":[187],"that":[188,208,226],"reverted":[190],"pre-intervention":[192],"levels":[193],"once":[194],"had":[200],"stopped.":[201],"CONCLUSIONS:":[202],"Our":[203,223],"provide":[205],"more":[206],"evidence":[207],"changing":[209],"laboratory":[210],"has":[214],"direct":[216],"effect":[217],"GPs.":[222],"indicate":[225],"much":[227],"attributable":[234],"use":[237,252],"persistent":[243],"or":[244],"recurrent":[245],"Microbiology":[247],"laboratories":[248],"can":[249],"influence":[250],"selectively":[254],"antibiotics":[256],"they":[257],"would":[258],"prefer":[259],"GPs":[260],"prescribe.":[262]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}